Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L1OT
|
|||
| Former ID |
DNCL003174
|
|||
| Drug Name |
TroVax
|
|||
| Synonyms |
TroVax (TN)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0] | Phase 3 | [1] | |
| Company |
Oxford BioMedica
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Oncotrophoblast glycoprotein 5T4 (TPBG) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00397345) TroVax Renal Immunotherapy Survival Trial. U.S. National Institutes of Health. | |||
| REF 2 | Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study. Clin Cancer Res. 2010 Nov 15;16(22):5539-47. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.